More News! 19 Nov 2018 Anti-Inflammatory Treatments Get €40M Boost in Series B A Series B funding round has whipped up €40M for the Irish company Inflazome. This money will help to fund clinical trials for anti-inflammatory treatments targeting conditions such as Alzheimer’s and Parkinson’s disease. “We are extremely excited about this opportunity, which is such a large funding round in a European company,” Marco Boorsma, General Partner […] November 19, 2018 - 2 minutesmins - By Jonathan Smith Share WhatsApp Twitter Linkedin Email
More News! 16 Nov 2018 AbbVie Enters Industry Collaboration to Fight Alzheimer’s and Parkinson’s Disease The UK biotech Mission Therapeutics has teamed up with AbbVie to develop new drugs to treat the neurodegenerative conditions Alzheimer’s disease and Parkinson’s disease. The new collaboration aims to fund the preclinical development of drugs that inhibit proteins called deubiquitinating enzymes. Deubiquitinating enzymes modify proteins in the cell, controlling essential functions such as what the […] November 16, 2018 - 2 minutesmins - By Jonathan Smith Share WhatsApp Twitter Linkedin Email
Startup Scout 16 Nov 2018 This Biotech Measures How Well Kidney Dialysis Machines Filter Your Blood We take a hop, skip and a jump into Tallinn, Estonia this week. Optofluid Technologies is developing sensors that measure blood toxin levels to see how well dialysis procedures are working in kidney failure patients. Mission: To improve the effectiveness of dialysis in kidney failure patients. Optofluid’s experimental optical sensor could give physicians detailed real-time […] November 16, 2018 - 3 minutesmins - By Jonathan Smith Share WhatsApp Twitter Linkedin Email
More News! 15 Nov 2018 Soldier Bug Could Help Combat Antibiotic Resistance A garden insect makes a molecule that attacks the cell wall of bacteria, providing a new potential weapon in the fight against antibiotic resistance. Thanatin is a peptide molecule produced by the spined soldier bug Podisus maculiventris to control the types of bacteria that live in its gut. A research group from the University of Zurich […] November 15, 2018 - 2 minutesmins - By Jonathan Smith Share WhatsApp Twitter Linkedin Email
Inside Labiotech 15 Nov 2018 Biotech Money Insider – A Year of Investments in Europe Did you ever dream of having access to all the recent investments in the European Biotech space? Well, I did! That’s why we created Biotech Money Insider, the first book by Labiotech.eu. Since we launched our website, back in 2014, we gathered data on over 1000 active biotech companies in Europe. This year, we decided […] November 15, 2018 - 1 minutemin - By Joachim Eeckhout Share WhatsApp Twitter Linkedin Email
News and Trends 14 Nov 2018 Parkinson’s Disease Vaccine Shows Preclinical Promise The biotech company United Neuroscience has developed a candidate Parkinson’s disease vaccine that targets a protein linked to the condition. The vaccine teaches the immune system to attack aggregations of alpha-synuclein. When this protein aggregates in neurons, it can lead to several neurodegenerative disorders, including Parkinson’s. In United Neuroscience’s preclinical study, the vaccine was able to prevent the […] November 14, 2018 - 2 minutesmins - By Jonathan Smith Share WhatsApp Twitter Linkedin Email
News and Trends 14 Nov 2018 CAR-T Promise for Patients with Solid Tumors A new CAR-T cancer therapy from the Belgian company Celyad has shown early positive results against solid tumors in two Phase I trials, including one trial that did not include add-on chemotherapy. In one ongoing Phase I trial, Celyad’s CAR-T therapy, combined with chemotherapy, successfully shrank tumors in three enrolled patients with aggressive colorectal cancer. One […] November 14, 2018 - 3 minutesmins - By Jonathan Smith Share WhatsApp Twitter Linkedin Email
In Depth 14 Nov 2018 Taking Biotech to the Next Level with Laboratory Automation Automation is slowly taking over our lives, ranging from smart homes to self-driving cars. With experiments becoming ever more complex and datasets more immense, a question that comes to mind: can we automate biotech research? Most pharma and biotech companies, and in part also academic labs, have automated sections of their processes and make use […] November 14, 2018 - 6 minutesmins - By Melanie De Almeida Share WhatsApp Twitter Linkedin Email
More News! 13 Nov 2018 French Company’s Drug Lowers Blood Pressure by Targeting Brain Proteins The French company Quantum Genomics is developing a first-in-class drug that targets proteins in the brain to lower blood pressure. A Phase IIb trial, run by Quantum Genomics, found that eight weeks of taking its drug significantly lowered blood pressure in patients who were overweight or obese and with high blood pressure. This reduction also […] November 13, 2018 - 2 minutesmins - By Jonathan Smith Share WhatsApp Twitter Linkedin Email
News and Trends 13 Nov 2018 Are Recent IPO Delays Bad News for European Biotech? Over the last two weeks, several biotech companies in Europe have decided to postpone IPOs on the stock markets — is this a sign that biotech stocks are underperforming? Since the end of October, several European biotech companies have delayed their IPOs — including Abacus Medicine on the Frankfurt stock exchange, Themis Bioscience on the […] November 13, 2018 - 4 minutesmins - By Clara Rodríguez Fernández Share WhatsApp Twitter Linkedin Email
More News! 12 Nov 2018 This UK Biotech Wants to Make Antibodies Easy to Swallow Say goodbye to painful antibody injections. The UK biotech Intract Pharma has received a €1.6M grant to advance oral immunotherapy based on approved antibodies, causing less discomfort for patients. The grant, awarded by public agency Innovate UK, will help Intract develop oral versions of existing antibody therapies. This could make the treatments easier for patients […] November 12, 2018 - 2 minutesmins - By Jonathan Smith Share WhatsApp Twitter Linkedin Email
News and Trends 10 Nov 2018 Stelarc — Making Art out of the Human Body From implanting a third ear on his arm to connecting his senses to the internet, Stelarc is an artist known for extreme performances that take the human body to the limit and blur the lines between technology and ourselves. On the inside of his left arm, Stelarc is in the process of ‘growing’ a third […] November 10, 2018 - 4 minutesmins - By Clara Rodríguez Fernández Share WhatsApp Twitter Linkedin Email